Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacologic resistance in colorectal cancer: a review.
Hammond WA, Swaika A, Mody K. Hammond WA, et al. Among authors: mody k. Ther Adv Med Oncol. 2016 Jan;8(1):57-84. doi: 10.1177/1758834015614530. Ther Adv Med Oncol. 2016. PMID: 26753006 Free PMC article. Review.
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.
Chakrabarti S, Tella SH, Kommalapati A, Huffman BM, Yadav S, Riaz IB, Goyal G, Mody K, Borad M, Cleary S, Smoot RL, Mahipal A. Chakrabarti S, et al. Among authors: mody k. J Gastrointest Oncol. 2019 Jun;10(3):554-561. doi: 10.21037/jgo.2019.01.35. J Gastrointest Oncol. 2019. PMID: 31183207 Free PMC article.
Albumin-bilirubin grade as a prognostic indicator for patients with non-hepatocellular primary and metastatic liver malignancy undergoing Yttrium-90 radioembolization using resin microspheres.
Azar A, Devcic Z, Paz-Fumagalli R, Vidal LLC, McKinney JM, Frey G, Lewis AR, Ritchie C, Starr JS, Mody K, Toskich B. Azar A, et al. Among authors: mody k. J Gastrointest Oncol. 2020 Aug;11(4):715-723. doi: 10.21037/jgo.2020.04.01. J Gastrointest Oncol. 2020. PMID: 32953155 Free PMC article.
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Barzi A, Weipert CM, Espenschied CR, Raymond VM, Wang-Gillam A, Nezami MA, Gordon EJ, Mahadevan D, Mody K. Barzi A, et al. Among authors: mody k. Front Oncol. 2024 Feb 8;14:1339302. doi: 10.3389/fonc.2024.1339302. eCollection 2024. Front Oncol. 2024. PMID: 38406801 Free PMC article.
208 results